Rui Pedro Moura is a PhD student at i3s in the Nanomedicines and Translational Drug Delivery research Group. He holds a MPharm in 2018 by Instituto Universitário de Ciências da Saúde. He has published three papers in Q1 journals and co-authored another one, authored 1 book chapter and co-authored another one. Furthermore, he has presented his research in multiple congress under Poster format. He also published a small impact newsletter article. In 2019, he won the Prémio Sociedade Farmacêutica Lusitana, from Ordem dos Farmacêuticos. His research interest include nanotechnology and nanotechnology-based approaches for central nervous system diseases, namely neurodegenerative diseases and cancer.
DOI: 10.1016/j.jconrel.2020.03.042 SCOPUS: 85082744990.
Moura R.P., Martins C., Pinto S., Sousa F., Sarmento B.,
DOI: 10.1080/17425247.2019.1583205 SCOPUS: 85063003421.
Moura R.P., Almeida A., Sarmento B.,
DOI: 10.1016/j.pneurobio.2017.09.001 SCOPUS: 85029183421.